
希格生科
希格生科
Biotech/Healthcare
Xige Biotech focuses on developing innovative small-molecule targeted cancer therapies and has assembled a world-leading R&D team. Its pipeline is designed to address the significant unmet need for targeted treatments for diffuse gastric cancer, potentially improving patient survival and creating…
Latest round: Series A (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-01-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.